Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Metivier

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1991
Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failureS J Marchais, I Boussac, A P Guerin, et al.
Kidney International|March 18, 2000
Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal diseaseB Pannier, A P Guerin, S J Marchais, et al.
American Journal of Hypertension|July 1, 1990
Parathyroid hormone and cardiovascular effects of dihydropyridines in chronic renal failureA P Guerin, G M London, S J Marchais, et al.
Journal of Human Hypertension|December 1, 1992
Effects of antihypertensive agents on carotid pulse contour in humansA P Guerin, B M Pannier, S J Marchais, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Interleukin-2 production after blood transfusions in prospective kidney transplant recipientsJ C Gluckman, D Klatzmann, F Triebel, et al.
Kidney International|August 1, 1996
Cardiac and arterial interactions in end-stage renal diseaseG M London, A P Guerin, S J Marchais, et al.
Circulation|July 1, 1990
Salt and water retention and calcium blockade in uremiaG M London, S J Marchais, A P Guerin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1989
Association between aluminum accumulation and cardiac hypertrophy in hemodialyzed patientsG M London, M C de Vernejoul, F Fabiani, et al.
International Journal of Clinical Practice|November 18, 2006
Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II studyA L M de Francisco, W Sulowicz, M Klinger, et al.
Kidney International|April 1, 1987
Uremic cardiomyopathy: an inadequate left ventricular hypertrophyG M London, F Fabiani, S J Marchais, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Cardiovascular Pharmacology|January 1, 1991
Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failureS J Marchais, I Boussac, A P Guerin, et al.
Kidney International|March 18, 2000
Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal diseaseB Pannier, A P Guerin, S J Marchais, et al.
American Journal of Hypertension|July 1, 1990
Parathyroid hormone and cardiovascular effects of dihydropyridines in chronic renal failureA P Guerin, G M London, S J Marchais, et al.
Journal of Human Hypertension|December 1, 1992
Effects of antihypertensive agents on carotid pulse contour in humansA P Guerin, B M Pannier, S J Marchais, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Interleukin-2 production after blood transfusions in prospective kidney transplant recipientsJ C Gluckman, D Klatzmann, F Triebel, et al.
Kidney International|August 1, 1996
Cardiac and arterial interactions in end-stage renal diseaseG M London, A P Guerin, S J Marchais, et al.
Circulation|July 1, 1990
Salt and water retention and calcium blockade in uremiaG M London, S J Marchais, A P Guerin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1989
Association between aluminum accumulation and cardiac hypertrophy in hemodialyzed patientsG M London, M C de Vernejoul, F Fabiani, et al.
International Journal of Clinical Practice|November 18, 2006
Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II studyA L M de Francisco, W Sulowicz, M Klinger, et al.
Kidney International|April 1, 1987
Uremic cardiomyopathy: an inadequate left ventricular hypertrophyG M London, F Fabiani, S J Marchais, et al.
Pageof 3